Description of Business

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Description of Business

Note 1. Description of Business

HTG Molecular Diagnostics, Inc. (the “Company”) is a commercial stage company that develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. The Company derives revenue from sales of the Company’s automation systems and integrated next-generation sequencing-based HTG EdgeSeq assays and from sample processing, custom research use only assay development, and collaboration services.

The Company operates in one segment and the majority of its customers are located in the United States. For the three and six months ended June 30, 2017 approximately 34% and 27%, respectively, of the Company’s revenue was generated from sales to customers located outside of the United States, compared with 10% for both the three and six months ended June 30, 2016.